PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 172 filers reported holding PDL BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $75,000 | -51.6% | 23,000 | -56.3% | 0.00% | – |
| Q2 2018 | $155,000 | 0.0% | 52,603 | 0.0% | 0.00% | – |
| Q1 2018 | $155,000 | -7.2% | 52,603 | -13.8% | 0.00% | – |
| Q4 2017 | $167,000 | +25.6% | 61,030 | +55.1% | 0.00% | – |
| Q3 2017 | $133,000 | -7.0% | 39,343 | -29.0% | 0.00% | – |
| Q2 2017 | $143,000 | +10.0% | 55,400 | -9.6% | 0.00% | – |
| Q4 2016 | $130,000 | -37.8% | 61,300 | -5.0% | 0.00% | -100.0% |
| Q3 2016 | $209,000 | +22.9% | 64,525 | +18.4% | 0.00% | 0.0% |
| Q2 2016 | $170,000 | – | 54,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |